As of March 1, 2024, an article processing charge (APC) of USD 400 + 20% VAT will be requested for newly submitted research, review, meta-analysis articles to the Anatolian Journal of Cardiology if they are accepted for publication.
The Anatolian Journal of Cardiology
A novel oral anticoagulant, dabigatran, in acute renal infarction [Anatol J Cardiol]
A novel oral anticoagulant, dabigatran, in acute renal infarction
Cihan Altın1, Onur Sakallıoğlu2, Esin Gezmiş3, Haldun Müderrisoğlu41Department of Cardiology, Faculty of Medicine, Başkent University; İzmir-Turkey 2Department of Nephrology, Faculty of Medicine, Başkent University; İzmir-Turkey 3Department of Radiology, Faculty of Medicine, Başkent University; İzmir-Turkey 4Department of Cardiology, Faculty of Medicine, Başkent University; Ankara-Turkey
Turkish
Başlık: Akut renal enfarktüsünde yeni kuşak oral antikoagülan dabigatran
Akut renal enfarktüsünde yeni kuşak oral antikoagülan dabigatran
Cihan Altın1, Onur Sakallıoğlu2, Esin Gezmiş3, Haldun Müderrisoğlu41Department of Cardiology, Faculty of Medicine, Başkent University; İzmir-Turkey 2Department of Nephrology, Faculty of Medicine, Başkent University; İzmir-Turkey 3Department of Radiology, Faculty of Medicine, Başkent University; İzmir-Turkey 4Department of Cardiology, Faculty of Medicine, Başkent University; Ankara-Turkey
Cihan Altın, Onur Sakallıoğlu, Esin Gezmiş, Haldun Müderrisoğlu. A novel oral anticoagulant, dabigatran, in acute renal infarction. Anatol J Cardiol. 2015; 15(2): 158-159 Manuscript Language: English